Prelude Therapeutics Incorporated PRLD
3.76 USD 0.00 (+0.00%)
At closeNov 11, 2026, 7:12 AM EST
3.66 -0.10 -2.66%
Pre-market · Nov 11, 7:12 AM ET
3.52 Day range 3.79
1.30 52-week range 6.83
- YTD
- +29.66%
- 1 year
- +198.41%
PRLD revenue history
Revenue is income from the company’s ordinary business activities.
12,140,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 12,140,000 | 5,140,000 | 73.43% |
| FY 2024 | 2024-12-31 | 7,000,000 | 7,000,000 | Not meaningful |
| FY 2023 | 2023-12-31 | 0 | 0 | Not meaningful |
| FY 2022 | 2022-12-31 | 0 | 0 | Not meaningful |
| FY 2021 | 2021-12-31 | 0 | 0 | Not meaningful |
| FY 2020 | 2020-12-31 | 0 | 0 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:42:25.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.